Evidence map›Paper›PMID 41728077›Full record

ArticleNanoscale advances2026

Nitrogen cavitation enables rapid and high-yield preparation of functional cell-membrane-derived vesicles.

Changting Li, Dehua Luo, Can Peng, Qun Luo, Wenjing Xu, Jincheng Zhou, Wen Su, Wei Wu, Yi-Feng Wang

Abstract read
In one paragraph

Article in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Changting LiGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.
Dehua LuoGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.
Can PengGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.
Qun LuoGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.
Wenjing XuDepartment of Pathology, Shenzhen University Shenzhen 518060 China.
Jincheng ZhouGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.
Wen SuDepartment of Pathology, Shenzhen University Shenzhen 518060 China.
Wei WuCancer Center, The First Hospital of Jilin University Changchun 130021 China.
Yi-Feng WangGuangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, School of Biomedical Engineering, Guangzhou Medical University Guangzhou 510260 Guangdong P. R. China lichangtingcurie@gmail.com yifengwang91@gmail.com.ORCID https://orcid.org/0009-0003-9951-8108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-membrane-derived vesicles (CMDVs) are increasingly utilized for the delivery of bioactive molecules due to their retention of membrane proteins, low immunogenicity, and biocompatibility. However, existing preparation methods (such as homogenization, sonication, and extrusion) struggle to strike a balance between scalability and structural integrity. More importantly, these methods lack subcellular selectivity, often leading to contamination from nuclei, mitochondria, lysosomes, and peroxisomes, which compromises the purity of the vesicles. Here, we present an optimized nitrogen cavitation-based workflow for the CMDV preparation within <2 hours. Using nanoluciferase-expressing HEK 293 cells (HEK 293_NLuc), we validated that this method is highly robust, allowing for successful CMDV generation under varying cell densities and pressures, as well as under high viscosity and salt conditions, with uniform particle size, minimal contamination, and preserved membrane-associated bioactivity. Functional assays confirmed enhanced cytotoxic T lymphocyte (CTL) cytotoxicity and enzymatic retention. This method offers a rapid, scalable, and function-preserving platform for CMDV production, enabling broad applications in drug delivery, immunotherapy, and biomimetic system design.

Identifiers

PMID41728077
PMCPMC12919722

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.